In this context, our study identifies Gnb5, a brain-enriched Gβ subunit of the GPCR complex, as a novel negative regulator of BACE1-mediated Aβ generation and a critical modulator of AD progression. The gene discussed is BACE1; the disease is Alzheimer disease.